Jeffrey C Pearson
Impact in
-
- Antibiotic Use and Resistance
-
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 5
- Tuberculosis Research and Epidemiology 5
- Antimicrobial Resistance in Staphylococcus 4
-
- Antibiotic Use and Resistance 6
- Co-authors
- Brandon Dionne (11 shared papers)David W. Kubiak (8 shared papers)Monica V. Golik Mahoney (4 shared papers)Christina Grace Rivera (2 shared papers)Zoe Weiss (1 shared paper)Thomas F. Byrd (1 shared paper)Kevin M. Dube (3 shared papers)Samuel J. Vidal (1 shared paper)
- Journals
- Open Forum Infectious Diseases (16 papers)Clinical Infectious Diseases (6 papers)Infectious Diseases and Therapy (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Lancet Infectious Diseases (1 paper)
- Partner nations
- United StatesSaudi ArabiaKuwait
In The Last Decade
Jeffrey C Pearson
32 papers receiving 277 citations
Jeffrey C Pearson's Hit Papers
Peers
Comparison fields: 5 of 63
- Applied Microbiology and Biotechnology 21
- Molecular Medicine 30
- Infectious Diseases 88
- Clinical Biochemistry 23
- Small Animals 22
Countries citing papers authored by Jeffrey C Pearson
This map shows the geographic impact of Jeffrey C Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C Pearson more than expected).
Fields of papers citing papers by Jeffrey C Pearson
This network shows the impact of papers produced by Jeffrey C Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C Pearson. The network helps show where Jeffrey C Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey C Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tetracyclines, the old and the new: A narrative review Hit paper breakdown → | 2025 | 41 |
| 2 | 2020 | 38 | |
| 3 | 2024 | 37 | |
| 4 | 2023 | 25 | |
| 5 | 2020 | 21 | |
| 6 | 2022 | 17 | |
| 7 | 2024 | 13 | |
| 8 | 2022 | 11 | |
| 9 | 2024 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2024 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2021 | 2 |
About Jeffrey C Pearson
Jeffrey C Pearson is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine and Pharmacology, having authored 38 papers that have together received 284 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Sepsis Diagnosis and Treatment (6 papers), Antibiotic Use and Resistance (6 papers), COVID-19 Clinical Research Studies (5 papers), Tuberculosis Research and Epidemiology (5 papers), Antibiotic Resistance in Bacteria (5 papers), Mycobacterium research and diagnosis (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (21 citations), Molecular Medicine (30 citations), Infectious Diseases (88 citations), Clinical Biochemistry (23 citations) and Small Animals (22 citations). Jeffrey C Pearson has collaborated with scholars based in United States, Saudi Arabia and Kuwait. Frequent co-authors include Brandon Dionne, David W. Kubiak, Monica V. Golik Mahoney, Christina Grace Rivera, Zoe Weiss, Thomas F. Byrd, Kevin M. Dube, Samuel J. Vidal, Aaron G. Richterman and Sigal Yawetz. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Infectious Diseases and Therapy, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.